Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Curran Biotech is a private Houston-based nanotechnology and materials manufacturing company developing coatings for HVAC filter media and other porous materials. Its flagship product, Capture Coating, is a patented waterborne nanocoating designed to enhance air filters by imparting superhydrophobicity, breathability, and non-toxicity without compromising airflow or filter ratings. The company positions the technology as a way to reduce airborne transmission risk by capturing liquid-borne contaminants, including virus-laden respiratory droplets, at the filter surface. Curran Biotech originated as a University of Houston spinout and markets its products across building, institutional, and distribution channels in North America and Europe. While it is not a drug-development biotech, it is healthcare-adjacent through indoor air quality and infection-control applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Curran Biotech.